Vecihi Batuman
Batuman, V.
Batuman, Vecihi
VIAF ID: 73720142 (Personal)
Permalink: http://viaf.org/viaf/73720142
Preferred Forms
- 100 1 _ ‡a Batuman, V.
-
-
- 100 1 _ ‡a Batuman, Vecihi
- 100 0 _ ‡a Vecihi Batuman
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
Acute tubulointerstitial nephritis after wasp stings. | |
Antidiuretic action of chlorpropamide | |
Association between the metabolic syndrome and chronic kidney disease in Chinese adults | |
Association of tibia lead and blood lead with end-stage renal disease: a pilot study of African-Americans | |
Balkan endemic nephropathy, c1991: | |
Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults | |
Blood lead level is associated with elevated blood pressure in blacks. | |
Continued decline in blood lead levels among adults in the United States: the National Health and Nutrition Examination Surveys | |
Contribution of lead to hypertension with renal impairment | |
Detection and treatment of occupational lead nephropathy | |
Edema in the nephrotic syndrome: new aspect of an old enigma | |
Effect of antitubular basement membrane and brush border antibodies on p-aminohippurate transport in kidney | |
The effect of PACAP38 on MyD88-mediated signal transduction in ischemia-/hypoxia-induced acute kidney injury | |
Elevated 1,25-dihydroxyvitamin D levels: occurrence with sarcoidosis with end-stage renal disease | |
Emergence of biomarkers in nephropharmacology | |
Estimated burden of blood lead levels 5 microg/dl in 1999-2002 and declines from 1988 to 1994. | |
The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group | |
Geophagic lead nephropathy: case report | |
HIV-associated renal disorders: recent insights into pathogenesis and treatment. | |
Insulin resistance and risk of chronic kidney disease in nondiabetic US adults | |
Lead chelation therapy retards the decline of renal function in patients with chronic kidney disease | |
Light chain effects on alanine and glucose uptake by renal brush border membranes | |
Light chains are a ligand for megalin | |
The long-term survival of simultaneous pancreas and kidney transplant with basiliximab induction therapy | |
Myeloma kidney with isolated tubulointerstitial light chain deposition in a renal allograft. | |
Myeloma light chain-induced renal injury in mice. | |
Nephrogenic systemic fibrosis and gadolinium-containing radiological contrast agents: an update | |
Parathyroid hormone status does not influence blood and bone lead levels in dialysis patients | |
The pathogenesis of acute kidney impairment in patients with multiple myeloma | |
Potential protective action of pituitary adenylate cyclase-activating polypeptide (PACAP38) on in vitro and in vivo models of myeloma kidney injury | |
Renal ischemia and transplantation predispose to vascular constriction mediated by angiotensin II type 1 receptor-activating antibodies. | |
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLH | |
The risk for mild kidney function decline associated with illicit drug use among hypertensive men. | |
The role of lead in gout nephropathy | |
Role of proximal tubules in the pathogenesis of kidney disease | |
The safety of the EDTA lead-mobilization test | |
Serum antioxidant vitamins and blood pressure in the United States population | |
Silencing megalin and cubilin genes inhibits myeloma light chain endocytosis and ameliorates toxicity in human renal proximal tubule epithelial cells | |
Stranded with the patients: a nephrologist's remembrances of hurricane Katrina | |
Treatment of renal failure associated with multiple myeloma and other diseases by PACAP-38 | |
Vitamin D: a new hope for chronic kidney disease? |